CLINICAL TRIALS PROFILE FOR ENABLEX
✉ Email this page to a colleague
All Clinical Trials for Enablex
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00127270 ↗ | Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder | Completed | Procter and Gamble | Phase 4 | 2005-05-01 | This study is designed to investigate the efficacy and safety of treatment of overactive bladder with darifenacin administered alone or in conjunction with behavioral modification therapies. |
NCT00127270 ↗ | Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder | Completed | Novartis | Phase 4 | 2005-05-01 | This study is designed to investigate the efficacy and safety of treatment of overactive bladder with darifenacin administered alone or in conjunction with behavioral modification therapies. |
NCT00170755 ↗ | A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder | Completed | Novartis | Phase 3 | 2002-04-01 | This study will evaluate the safety, tolerability and efficacy of darifenacin, in the long-term treatment of adult patients with overactive bladder. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Enablex
Condition Name
Clinical Trial Locations for Enablex
Trials by Country
Clinical Trial Progress for Enablex
Clinical Trial Phase
Clinical Trial Sponsors for Enablex
Sponsor Name